Development of a core outcome set for myelodysplastic syndromes – a Delphi study from the EUMDS Registry Group

Treatment options for myelodysplastic syndromes (MDS) vary widely, depending on the natural disease course and patient‐related factors. Comparison of treatment effectiveness is challenging as different endpoints have been included in clinical trials and outcome reporting. Our goal was to develop the...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Haematol
Hlavní autoři: Rochau, Ursula, Stojkov, Igor, Conrads‐Frank, Annette, Borba, Helena H., Koinig, Karin A., Arvandi, Marjan, van Marrewijk, Corine, Garelius, Hege, Germing, Ulrich, Symeonidis, Argiris, Sanz, Guillermo F., Fenaux, Pierre, de Witte, Theo, Efficace, Fabio, Siebert, Uwe, Stauder, Reinhard
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Haematological Malignancy ‐ Clinical
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8221029/
https://ncbi.nlm.nih.gov/pubmed/32410281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.16654
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky